Fig. 5
From: Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors
Clinical outcomes after MPTK-CAR-T cell infusion. A Swimmer plot indicating the disease status and survival of all 15 treated patients (black arrowheads indicate ongoing survival). PD progressive disease and SD stable disease. B Imaging changes in the target lesion before and at several time points after infusion
